Director, Directorate Health,
Directorate-General for Research,
Dr. Ruxandra Draghia-Akli is Director of the Health Directorate at the Research DG of the European Commission.
Previously Ruxandra Draghia-Akli, MD, PhD served as the Vice President of Research at VGX Pharmaceuticals and VGX Animal Health (ADViSYS). With 15 years of experience, she is recognised as a global leader in the field of DNA delivery for therapeutic and vaccination applications.
Dr. Draghia's research activities have focused on plasmid design, gene expression and tissue-specific promoter/enhancer fragments and DNA sequences that allow for the efficient expression of either secreted or intracellular proteins for gene therapy and vaccination.
Throughout her career, Dr. Draghia has published numerous scientific papers and reviews in the areas of electroporation, plasmid components, growth and development, immune stimulation, health, and well-being. Dr. Draghia-Akli also served as an ad hoc reviewer for granting agencies, such as the European Union, USDA and NIH, annual meeting for gene therapy and endocrinology societies, and has produced manuscripts for numerous journals.
Dr. Draghia received an M.D. from Carol Davilla Medical School and a Ph.D. in human genetics from the Romanian Academy of Medical Sciences.
Dr. Draghia also completed a doctoral fellowship at the University of Rene Descartes in Paris and a post-doctoral training at Baylor College of Medicine, Houston, Texas, USA, and served as faculty at BCM.